Provided by Tiger Trade Technology Pte. Ltd.

Olema Pharmaceuticals, Inc.

13.67
-0.4500-3.19%
Post-market: 13.41-0.2600-1.90%17:20 EDT
Volume:1.20M
Turnover:16.48M
Market Cap:1.19B
PE:-7.31
High:14.13
Open:13.75
Low:13.34
Close:14.12
52wk High:36.26
52wk Low:2.86
Shares:87.16M
Float Shares:71.89M
Volume Ratio:0.45
T/O Rate:1.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8700
EPS(LYR):-1.8700
ROE:-36.61%
ROA:-21.42%
PB:2.49
PE(LYR):-7.31

Loading ...

BRIEF-Olema Pharmaceuticals Q4 Net Income USD -46.061 Million

Reuters
·
Mar 16

Olema Pharmaceuticals Q4 EPS USD -0.5

THOMSON REUTERS
·
Mar 16

Olema Pharmaceuticals Q4 Income From Operations USD -50.084 Million

THOMSON REUTERS
·
Mar 16

Olema Pharmaceuticals Inc - to Report Phase 3 Opera-01 Top-Line Data in Fall 2026

THOMSON REUTERS
·
Mar 16

Olema Pharmaceuticals Inc - Continues Enrollment in Phase 1 Study of Op-3136; Initial Data Expected Q2 2026

THOMSON REUTERS
·
Mar 16

Press Release: Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Dow Jones
·
Mar 16

Olema Pharmaceuticals Inc expected to post a loss of 53 cents a share - Earnings Preview

Reuters
·
Mar 13

What's Going On With Olema Pharmaceuticals Stock On Wednesday?

Benzinga_recent_news
·
Mar 11

Olema Pharmaceuticals Down Over 22%, on Pace for Largest Percent Decrease Since August 2022 -- Data Talk

Dow Jones
·
Mar 10

Olema Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 10

Why Is Olema Pharmaceuticals Stock Dropping On Monday?

Benzinga_recent_news
·
Mar 10

Maintaining a Buy on Olema: Differentiated Palazestrant Profile Supports Upside Despite Negative Giredestrant Read-Through

TIPRANKS
·
Mar 09

Constructive Read‑Through From Giredestrant Data Supports Olema’s Palazestrant and Underpins Buy Rating Despite Sector Setbacks

TIPRANKS
·
Mar 09

Top Premarket Decliners

MT Newswires Live
·
Mar 09

Olema Chief Legal Officer Shawnte Mitchell Disposes of Common Shares in Olema Pharmaceuticals Inc

Reuters
·
Mar 06

Olema Grants 205,000 Inducement Stock Options to Four New Hires

Reuters
·
Mar 04

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Mar 04

How Leadership Turnover and Palazestrant Optimism At Olema Pharmaceuticals (OLMA) Has Changed Its Investment Story

Simply Wall St.
·
Mar 03

Olema Pharmaceuticals (OLMA) Valuation Check After Recent Share Price Volatility

Simply Wall St.
·
Feb 28

Olema CEO Sean P. Bohen to Present at TD Cowen 46th Annual Health Care Conference

Reuters
·
Feb 20